BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32435479)

  • 1. Adhering to antiretroviral therapy: A qualitative analysis of motivations for and obstacles to consistent use of antiretroviral therapy in people living with HIV.
    Fleischer L; Avery A
    SAGE Open Med; 2020; 8():2050312120915405. PubMed ID: 32435479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pharmacy personnel in promoting adherence to antiretroviral therapy in the Eastern Cape: communication barriers and breakthroughs.
    Rattine-Flaherty E; Burton S
    Afr J AIDS Res; 2021 Jul; 20(2):165-171. PubMed ID: 34264163
    [No Abstract]   [Full Text] [Related]  

  • 4. A qualitative study of community home-based care and antiretroviral adherence in Swaziland.
    Root R; Whiteside A
    J Int AIDS Soc; 2013 Oct; 16():17978. PubMed ID: 24107652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and feasibility of short message service to improve ART medication adherence among people living with HIV/AIDS receiving antiretroviral treatment at Adama hospital medical college, Central Ethiopia.
    Endebu T; Deksisa A; Dugasa W; Mulu E; Bogale T
    BMC Public Health; 2019 Oct; 19(1):1315. PubMed ID: 31638936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom.
    Bolsewicz K; Debattista J; Vallely A; Whittaker A; Fitzgerald L
    AIDS Care; 2015; 27(12):1429-38. PubMed ID: 26641139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda.
    Bukenya D; Mayanja BN; Nakamanya S; Muhumuza R; Seeley J
    AIDS Res Ther; 2019 Jan; 16(1):2. PubMed ID: 30665440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
    Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
    J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "The sky is the limit": adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers.
    Denison JA; Banda H; Dennis AC; Packer C; Nyambe N; Stalter RM; Mwansa JK; Katayamoyo P; McCarraher DR
    J Int AIDS Soc; 2015; 18(1):19358. PubMed ID: 25591915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?
    Kremer H; Bader A; O'Cleirigh C; Bierhoff HW; Brockmeyer NH
    Eur J Med Res; 2004 Feb; 9(2):61-70. PubMed ID: 15090291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
    Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
    JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to HIV care and adherence for young people living with HIV in Zambia and mHealth.
    St Clair-Sullivan N; Mwamba C; Whetham J; Bolton Moore C; Darking M; Vera J
    Mhealth; 2019; 5():45. PubMed ID: 31620472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical and Psychosocial Challenges of mHealth Usage for Antiretroviral Therapy Adherence Among People Living With HIV in a Resource-Limited Setting: Case Series.
    Ngowi KM; Lyamuya F; Mmbaga BT; Muro E; Hillu Z; Shirima M; Aarnoutse RE; Ag Sprangers M; Nieuwkerk PT; Reiss P; Sumari-de Boer M
    JMIR Form Res; 2020 Jun; 4(6):e14649. PubMed ID: 32519966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the FITT framework to understand patients' experiences using a real-time medication monitoring pill bottle linked to a mobile-based HIV self-management app: A qualitative study.
    Cho H; Flynn G; Saylor M; Gradilla M; Schnall R
    Int J Med Inform; 2019 Nov; 131():103949. PubMed ID: 31561192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication beliefs and structural barriers to treatment adherence among people living with HIV infection.
    Kalichman S; Kalichman MO; Cherry C
    Psychol Health; 2016; 31(4):383-95. PubMed ID: 26534788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of non-compliance with Antiretroviral Therapy among adults living with HIV/AIDS: A Systematic Review.
    Gemeda DH; Gebretsadik LA; Dejene T; Wolde M; Sudhakar M
    JBI Libr Syst Rev; 2012; 10(56):3596-3648. PubMed ID: 27820502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "We give them threatening adviceā€¦": expectations of adherence to antiretroviral therapy and their consequences among adolescents living with HIV in rural Malawi.
    Burns R; Magalasi D; Blasco P; Szumilin E; Pasquier E; Schramm B; Wringe A
    J Int AIDS Soc; 2020 Mar; 23(3):e25459. PubMed ID: 32124554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen's Behavioral Model.
    Holtzman CW; Shea JA; Glanz K; Jacobs LM; Gross R; Hines J; Mounzer K; Samuel R; Metlay JP; Yehia BR
    AIDS Care; 2015; 27(7):817-28. PubMed ID: 25671515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How food insecurity contributes to poor HIV health outcomes: Qualitative evidence from the San Francisco Bay Area.
    Whittle HJ; Palar K; Seligman HK; Napoles T; Frongillo EA; Weiser SD
    Soc Sci Med; 2016 Dec; 170():228-236. PubMed ID: 27771206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
    Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
    Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.